Vistagen Therapeutics CEO Shawn Singh's 2020 pay slips 2% to $934K
Vistagen Therapeutics reports 2020 executive compensation
By ExecPay News
Published: July 27, 2020
Vistagen Therapeutics reported fiscal year 2020 executive compensation information on July 27, 2020.
In 2020, five executives at Vistagen Therapeutics received on average a compensation package of $656K, which is about the same as previous year.
Shawn K. Singh, Chief Executive Officer, received $934K in total, which decreased by 2% compared to 2019. 53% of Singh's compensation, or $498K, was in salary. Singh also received $436K in option awards.
H. Ralph Snodgrass, Chief Scientific Officer, received a compensation package of $671K, which increased by 5% compared to previous year. 62% of the compensation package, or $417K, was in salary.
Jerrold D. Dotson, Chief Financial Officer, earned $597K in 2020, a 10% increase compared to previous year.
Mark A. Smith, Chief Medical Officer, received $597K in 2020, which decreases by 4% compared to 2019.
Mark A. McPartland, Vice President, Corporate Development, earned $480K in 2020, a 5% decrease compared to previous year.
Vistagen Therapeutics' fiscal year ends on March 31.